Neutrophils are heterogeneous with distinct subsets, and can switch phenotypes to exert regulatory functions on immunity. We herein demonstrate that IL-23-treated neutrophils selectively produce IL-17A, IL-17F and IL-22, and display a distinct gene expression profile in contrast to resting and lipopolysaccharide-treated neutrophils. IL-17 + neutrophils are present in the colons of mice with dextran sulfate sodium-induced colitis. Adoptive transfer of IL-23-treated neutrophils significantly promotes pathogenesis in this model. IL-23 induces neutrophil polarization through STAT3-dependent RORγt and BATF pathways. Thus, IL-23-induced neutrophil polarization expresses a unique cytokine-producing profile, which may contribute to IL-23-mediated inflammatory diseases.
INTRODUCTION
Polymorphonuclear neutrophil granulocytes (also called neutrophils) are fully equipped with a variety of granules that are essential for host defense against intruding microorganisms and play a critical role in initiating inflammation and innate immunity. [1] [2] [3] [4] However, neutrophils also significantly contribute to various types of acute and chronic pathological damage during infections, autoimmune diseases and graft rejections in either a positive or a negative manner. [5] [6] [7] [8] In fact, in addition to their direct cytotoxicity against invading pathogens, neutrophils can switch phenotypes and exert regulatory functions in both innate and adaptive immunity. [9] [10] [11] [12] Neutrophils from rheumatoid arthritis patients upregulate MHC-II expression and increase their antigen-presenting ability, leading to T lymphocyte activation. 13 New evidence has also shown that in certain situations neutrophils can be activated to play a role as antigen-presenting cells. 14 Recent studies have indicated that neutrophils exhibit considerable functional plasticity and polarization. Similar to macrophage activation pathways, neutrophils have distinctive subsets, as presented in infections and tumors. [15] [16] [17] A subpopulation of neutrophils present in the spleen produces CD40L, BAFF, APRIL and interleukin-21 (IL-21) and has the ability to activate marginal-zone B cells, and subsequently promotes immunoglobulin class-switching, somatic hypermutation and antibody production. 18 Tumorassociated neutrophils have been proposed to be polarized between antitumorigenic and protumorigenic neutrophil phenotypes. 19 However, the extracellular inducing factors, the intracellular molecular regulatory networks, the phenotype characteristics and the biological significance of 1 the polarized neutrophils are unclear and require further determination.
IL-23 is crucial in the pathogenesis of psoriasis, experimental autoimmune encephalomyelitis (EAE), inflammatory bowel disease (IBD) and collagen-induced arthritis (CIA). [20] [21] [22] Genetic polymorphisms in the IL-23 receptor (IL-23R) are important susceptibility factors for Bechet's disease, ankylosing spondylitis and IBDs such as Crohn's disease and ulcerative colitis. 23, 24 It is known that IL-23 is essential for the terminal differentiation of IL-17-producing T effector cells. 25, 26 However, IL-23R is predominantly found on natural killer cells, innate lymphoid cells (ILCs) and activated memory T cells, and at lower levels on dendritic cells (DCs), monocytes and macrophages in humans, whereas mouse IL-23R is expressed on activated T cells, ILCs, γδ T cells, macrophages and DCs. [27] [28] [29] Importantly, studies have demonstrated that IL-23 induces these innate cells to secrete IL-17 and/or IL-22. 30, 31 In the present study, we demonstrate that IL-23-treated neutrophils selectively produce IL-17A, IL-17F and IL-22, and display a distinct lineage gene expression profile in sharp contrast to resting and lipopolysaccharide (LPS)-treated neutrophils. IL-17-expressing neutrophils are present in the intestines of mice with dextran sulfate sodium (DSS)-induced colitis. Moreover, adoptive transfer of IL-23-treated neutrophils significantly promotes the severity of the pathogenesis of DSS-induced colitis in WT or IL-17 knockout (KO) recipient animals. IL-23 induces neutrophil polarization through STAT3-dependent BATF and RORγT pathways. Thus, our present studies reveal neutrophil polarization with a unique cytokine-producing gene profile driven by IL-23. This IL-23-induced neutrophil subpopulation may make significant contributions to IL-23-related pathologies.
MATERIALS AND METHODS
Mice BALB/c and C57BL/6 (B6) mice were purchased from the Beijing University Experimental Animal Center (Beijing, China). IL-17 KO mice were kindly provided by the Key Laboratory of Human Diseases Comparative Medicine, the Ministry of Public Health; Institute of Laboratory Animal Science, CAMS & PUMC (Beijing, China). 32 All mice were bred and maintained in specific pathogen-free conditions. Sixto-twelve-week-old sex-matched littermate mice were mainly used for the experiments unless otherwise noted. All experimental manipulations were undertaken in accordance with the Institutional Guidelines for the Care and Use of Laboratory Animals, Institute of Zoology.
Reagents
Anti-mCD11b-PE-Cy5 was purchased from BD Biosciences Pharmingen (San Diego, CA, USA). Anti-mLy6G-PE was purchased from eBioscience (San Diego, CA, USA). AntimIL-17A-PE was purchased from Biolegend (San Diego, CA, USA). Anti-mIL-23R-AF488 mAb was purchased from R&D Systems (Minneapolis, MN, USA). Bacterial lipopolysaccharide (E. coli 055:B5) was purchased from Sigma-Aldrich (St Louis, MO, USA). Recombinant mouse cytokines were purchased from PeproTech (Rocky Hill, NJ, USA). A selective STAT3 inhibitor (S3I-201) was purchased from Sigma-Aldrich. Primary antibodies against p-STAT3 (705), BATF were purchased from Cell Signaling Technology (Danvers, MA, USA). RORγT antibody was purchased from Millipore Biotechnology (Billerica, MA, USA). These antibodies were diluted at 1:1000 in 5% bovine serum albumin (BSA). Anti-β-actin mAb was purchased from Sigma-Aldrich and its working concentration (1:50 000) was determined in previous studies. 33, 34 Recombinant mouse cytokines were used at the following concentrations based on our previous studies: 35 recombinant mouse IL-1β (100 ng/ml, PeproTech), IL-2 (10 ng/ml, PeproTech), IL-4 (10 ng/ml, R&D Systems), IL-6 (50 ng/ml, PeproTech), IL-10 (20 ng/ml, PeproTech), IL-12 (5 ng/ml, PeproTech), IL-13 (50 ng/ml, PeproTech), IL-17A (100 ng/ml, PeproTech), IL-21 (50 ng/ml, R&D Systems), IL-23 (10 ng/ml, R&D Systems), IL-33 (100 ng/ml, R&D Systems), LPS (1 μg/ml, Sigma-Aldrich), IFN-γ (100 ng/ml, PeproTech), TNF-α (100 ng/ml, PeproTech), TGF-β1 (5 ng/ml, R&D Systems), GM-CSF (40 ng/ml, R&D Systems) and G-CSF (100 ng/ml, Biovision, Milpitas, CA, USA).
Isolation and differentiation of neutrophils in vitro
Tibiae and femora from BALB/c or B6 mice were removed using sterile techniques, and bone marrow was flushed with PBS. Red blood cells were lysed with ammonium chloride. Primary neutrophils (CD11b + Ly6G + F4/80 − ) were isolated from bone marrow cells with 52% percoll (GE Healthcare Life Sciences, Piscataway, NJ, USA, 17-0891-01) and sorted by MoFlo XDP (Beckman Coulter) in several cases. 36 Primary neutrophils (2 × 10 6 cells per ml in 48-well plates) were cultured with IL-23 (50 ng/ml) for different time courses as indicated in RPMI 1640 medium supplemented with 2 mM L-glutamine, 10 mM HEPES, 20 μM 2-ME, 150 U/ml streptomycin, 200 U/ml penicillin and 5% heat-inactivated FBS at 37°C and 5% CO 2 . The cytokine expressions and phenotypes of neutrophils were characterized by real-time PCR, ELISA assays and flow cytometric analysis.
Microarray hybridization and data acquisition
The neutrophils were stimulated by LPS (1 μg/ml) and IL-23 (50 ng/ml). TRIzol Reagent (Life Technologies, Gaithersburg, MD, USA, 15596-018) was used to extract total RNA following the manufacturer's instructions. 
Microarray data analysis
Lineage-restricted genes were defined as the genes the expression levels of which were at least two-fold greater in one cell type than in any other cell type. R (version 3.0.2) was used to draw the heatmap of lineage-restricted genes. The fold-changes were calculated as the ratio of the expression level in each cell type versus the second-highest expression level in all cell types. Differentially expressed genes were defined as genes with at least two-fold variance of expression levels in LPS-and IL-23-treated neutrophils compared with untreated neutrophils.
Quantitative PCR analysis
The neutrophils were stimulated by LPS (1 μg/ml) and IL-23 (50 ng/ml) at different time points. Total RNA was isolated with TRIzol (Invitrogen) and reverse transcription was performed with M-MLV superscript reverse transcriptase as described previously. Real-time PCR was performed using multiple kits (SYBR Premix Ex Taq, DRR041A, Takara Bio) on CFX96 (Bio-Rad Laboratories, Hercules, CA, USA). The primers utilized are summarized in Table 1 . The mRNA expression level of each gene was normalized to the housekeeping gene hypoxanthinephosphoribosyl transferase (HPRT), as reported previously. 33, 37 For the inhibitor assay, cells were pretreated with various inhibitors for 30 min, and then treated with IL-23 for 12 h.
Flow cytometry
For flow cytometric analysis of surface markers, cells were stained with antibodies in PBS containing 0.1% (w/v) BSA and 0.1% NaN 3 as described previously. 38 For the detection of intracellular cytokines, neutrophils were treated with GolgiPlug (BD Biosciences, San Jose, CA, USA) for the last 4-6 h of incubation. Cells were fixed and permeabilized according to the manufacturer's protocol (BD Bioscience) and stained with anti-IL-17 mAb (1:100). Flow cytometry data were acquired on a FACSCalibur (BD Biosciences) or Epics XL (Beckman Coulter, Brea, CA, USA) and analyzed with FCS Express Version 3.0 software (De Novo Software) or FlowJo Version 7.6.5 software (TreeStar Inc., Ashland, OR, USA).
Western blotting
Neutrophils were cultured in RPMI 1640 medium with 5% FCS in 12-well plates. Cells were treated with IL-23 (50 ng/ml) or LPS (1 μg/ml) for the indicated times. After stimulation, cells were washed once in cold PBS, lysed in RIPA buffer (50 mM Tris-HCl pH 7.4, 1% NP-40, 0.25% Na-deoxycholate, 150 mM NaCl, 1 mM EDTA pH 7.4) with protease and phosphatase inhibitor cocktails (Sigma) for 10 min on a rocker at 4°C as described previously. 39 Protein concentration was determined using a BCA assay. Protein samples were analyzed by SDS polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto PVDF membranes (Millipore, Ternicula, CA, USA). Each polyvinylidene fluoride membrane was blocked with TBST (100 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.05% Tween20) with 5% non-fat dried milk for 1 h, then incubated with primary antibodies overnight on a shaker at 4°C. The appropriate HRP-conjugated secondary antibody was then added and was detected through a Tanon 1600R Gel Image System (Tanon Co., Ltd, Shanghai, China). Actin was used as a protein loading control.
ELISA assays IL-17A (432508), IL-17F (436107) and IL-22 (436307) ELISA assay kits were purchased from Biolegend. The ELISA assay was performed following the manufacturer's instructions. Briefly, pre-coated ELISA plates were blocked with 5% BSA/PBS at room temperature for ⩾ 1 h. After washing three times with PBS/Tween20, standards and samples were added to pre-coated ELISA plates and incubated at room temperature for 2-4 h. After washing, specific cytokine detection antibodies were added for 1 h at 30°C followed by Avidin-HRP A for 1 h at 30°C. Plates were developed using Substrate Solution E. The reaction was stopped with the Stop Solution and optical densities were determined at 450 nm using a plate reader.
Immunofluorescent staining
Cells were cultured on coverslips for the indicated times and fixed in 4% paraformaldehyde for 10 min. 35 Cells were permeabilized with 0.2% Triton X-100 (v/v) in PBS for 10 min at room temperature and blocked for 1 h in 5% BSA/ PBS, and incubated overnight in indicated primary mAbs (1:100 dilution in blocking buffer) at 4°C. Following PBS washes, secondary Ab (FITC-or PE-labeled goat anti-rabbit Ab, Santa Cruz Biotechnology, Santa Cruz, CA, USA; 1:500 dilution) was applied for 1 h followed by Hoechst 33342 (2 μg/ ml) staining for 10 min before the coverslips were washed in PBS and mounted. Photomicrographs were taken using an LSM510META Laser Scanning Microscope (Zeiss, Germany).
IBD model and histological examination
Recipient B6 mice were i.v.-injected with 5 × 10 6 sorted neutrophils stimulated with IL-23 for 12 h on days 0, 2, 5 and 8. Colitis was induced by the administration of dextran sulfate sodium (2.5%) in drinking water. The disease activity index (DAI) 40 and body weight of each animal were monitored daily. DAI was determined by scoring the loss of body weight, characteristics of the stool, and occult blood in stool or hematochezia (over the entire period), according to the classic scoring system by Cooper with modification. The scoring process is given as follows: body weight loss (0, none; 1, 1-5%; 2, 5-20%; 3, 420%), stool consistency (0, normal; 2, loose stool; 3, diarrhea) and stool blood (0, negative; 2, fecal occult blood test positive; 3, gross bleeding). The animals were killed on day 7 of the experiment, and the colonic tissue was removed and cleaned, and then subjected to cell culture, followed by quantitative real-time PCR and histological analyses.
Statistical analysis
All data are presented as the mean ± s.d. Two-way ANOVA analysis was used for comparisons among multiple groups with SPSS 16.0 software. A Mann-Whitney U-test was used for comparisons between the two groups. A P-value o0.05 was considered statistically significant.
RESULTS

IL-23 selectively induces Th17 cytokine expression in neutrophils
In addition to participating in primary defense against infections, neutrophils produce and release a large number of cytokines and chemokines either constitutively or upon microenvironmental stimulations that play a critical role in infections and pathologies. [41] [42] [43] [44] To explore the roles of different cytokines on the expression of IL-17 family members in neutrophils, we first detected the mRNA expression levels of these genes in freshly isolated neutrophils from mouse bone marrow after different cytokine and LPS stimulation for 24 h by real-time PCR. Among the 17 cytokines and LPS stimulations studied, only IL-23 significantly promoted IL-17A and IL-17F expression, while resting neutrophils expressed nearly undetectable levels of IL-17A and IL-17F (Po0.001, Figure 1a ). In addition, IL-23 also specifically induced significant IL-22 expression compared with other cytokines and LPS (Po0.001, Figure 1a ). IL-23 induced IL-17A, IL-17F and IL-22 mRNA expression in dose-and time-dependent manners, as determined by real-time PCR (Figures 1b and c) . The possible direct effects of IL-23 on neutrophils were supported by the expression of IL-23R on neutrophils as detected by flow cytometry, which showed that approximately 10% of neutrophils are positive for IL-23R (Supplementary Figure 1) . To exclude the potential contamination of other immune cells such as T cells, B cells and ILCs during the differentiation process in vitro, we sorted the neutrophils of naïve mice to obtain highly purified CD11b + Ly6G + cells with more than 99% purity and repeated the same induction experiments. Indeed, the sorted CD11b + Ly6G + cells expressed high levels of IL-17A, IL-17F and IL-22 after IL-23 treatment at both the mRNA and the protein levels (Po0.001, Figure 1d, Supplementary Figure 2) . The protein levels of IL-17A in the culture medium of IL-23-treated sorted neutrophils were significantly increased with increasing IL-23 doses, as detected by ELISA assays, indicating that IL-23-treated neutrophils have the ability to secrete IL-17A (Po0.01, Figure 1e ). The expression of IL-17A in IL-23-treated neutrophils was further confirmed by flow cytometry and confocal microscopy staining (Figures 1f and g ). By contrast, the sorted IL-23R-deficient neutrophils failed to express IL--17A, IL-17F and IL-22 after IL-23 treatment (Supplementary Figure 3) . Thus, IL-23, but not other cytokines or LPS, has the ability to promote the expression of the Th17-type cytokines IL-17A, IL-17F and IL-22 in resting mouse neutrophils.
IL-23 induces a distinct gene expression profile in neutrophils
To investigate whether IL-23 induces a unique neutrophil polarization profile, in contrast to the LPS-induced inflammatory neutrophil subpopulation, we determined the gene expression profiles of LPS-polarized neutrophils and IL-23-induced neutrophils by microarray analysis. Indeed, IL-23-induced neutrophils express a unique panel of genes in sharp contrast to resting and LPS-stimulated neutrophils (Figure 2a) . Specifically, 1362 genes were upregulated and 1438 genes were downregulated in IL-23-treated neutrophils compared with untreated and LPS-polarized neutrophils (Figures 2a and b) . Interestingly, LPS-and IL-23-induced neutrophils express distinctive gene profiles and kinetics of cytokine induction, as indicated by mRNA microarray analysis and confirmed by realtime PCR assays (Figures 2c-e) . LPS induces TNF-α and IL-6 expression in neutrophils at the mRNA level (Figure 2d ). However, IL-23 fails to induce the expression of TNF-α and IL-6 ( Figure 2d ). By contrast, IL-23 specifically promotes the expression of IL-17A, IL-17F and IL-22 at both the mRNA and the protein levels in neutrophils (Po0.01, Figures 2d and e) . Altogether, these data lead us to speculate that IL-23 may drive the polarization of resting neutrophils into a subpopulation with a distinct panel of cytokines compared with LPS-induced inflammatory neutrophils.
IL-23 induces Th17 cytokine expression in neutrophils via STAT3-dependent pathways
It has been reported that RORγT, RORα, IRF-7, IRF4, BATF, Sox5 and C-maf are critical transcription factors for Th17 cell induction. [45] [46] [47] The expression of BATF, RORγT, IRF4 and IRF7 is enhanced in IL-23-treated neutrophils at the mRNA level, and the protein level expression of BATF and RORγT is upregulated in IL-23-treated neutrophils (Figures 3a and b) . However, the expression of Sox5 and C-maf in IL-23-treated (Figure 3a) . Thus, the enhanced expression of BATF and RORγT suggested that they are likely involved in IL-23-stimulated neutrophil polarization. It has been reported that IL-23 promotes STAT3 activation in T cells based on the enhanced levels of p-STAT3 (at amino acids Y705 and S727). 21, 48 The level of p-STAT3 in neutrophils is increased after IL-23 treatment (Figure 3c ). , representing one of three independent experiments. *Po0.05, **Po0.01 and ***Po0.001 compared with control group. Data were analyzed by Mann-Whitney U-test for two group comparisons or one-way ANOVA analysis for multi-group comparisons using SPSS software. LPS, lipopolysaccharide.
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and neutrophils have been reported to play a critical role. 14 Mice with DSS-induced colitis showed enhanced IL-17A and IL-22 expression in colon tissues (Figures 4a and b) . Importantly, IL-17A + neutrophils were present in the colons of DSS-induced colitis mice, as detected by flow cytometry (Figure 4c ). Using the neutrophil-depleting antibody RB6-8C5, we found that neutrophil depletion significantly reduced the expression of IL-17A, IL-17F and IL-22 in colon tissues ( Supplementary Figures 4a and b) , which supports the contribution of neutrophils to these cytokines in colitis. To identify the role of IL-17-producing neutrophils in the pathogenesis of colitis, we adoptively transferred either induced IL-23-treated or resting neutrophils into recipient mice during the administration of DSS. Mice that received IL-23-treated neutrophils displayed more severe symptoms of acute colitis than mice that either received untreated neutrophils or did not receive neutrophils, as shown by significantly shorter survival times (Figure 4d ), rapid body weight loss (Figure 4e ), increased macroscopic scores (Figure 4f ) and shorter colon lengths (Figure 4g ) in the mice that received IL-23-treated neutrophils. The median survival times for mice not receiving neutrophils, and for mice receiving untreated, or IL-23-treated neutrophils -5) and one representative example from three independent experiments with similar results is shown. *Po0.05, **Po0.01 and ***Po0.001 for comparisons between the indicated groups. Data were analyzed by the Mann-Whitney U-test or two-way ANOVA using SPSS software. Survival curves were analyzed by the log-rank test.
IL-23-induced neutrophil polarization Y Li et al produce more Th17-type cytokines including IL-17A, IL-17F and IL-22 and less TNF-α and IL-1β; (c) to promote colitis pathogenesis; and (d) to activate the specific transcription factors RORγT and BATF downstream of STAT3. Thus, we provide additional evidence for differentially polarized neutrophils with respect to cytokine production. We believe that relevant studies may provide new insights into the contribution of neutrophils to the pathogenesis of inflammation and immune disorders and may provide new therapeutic approaches to treat neutrophil-related diseases. Genetic studies have strongly indicated that IL-23 may significantly contribute to inflammatory disease risk in humans. 49, 50 Deficiency of IL-23 in mice causes resistance to experimental immune-mediated diseases such as IBD. 51, 52 The promotion of Th17 subsets is highly recognized as a key player for mediating the critical role of IL-23 in these inflammatory diseases. 20, 53 Our present study showed that IL-17A + neutrophils are present in colonic tissues with colitis. IL-23 acts directly on neutrophils to induce IL-17A and IL-17F, and the adaptive transfer of IL-23-treated neutrophils significantly increases the severity of colitis in mice, indicating that IL-17A-producing neutrophils may promote the pathogenesis of colitis in mice. The significance of IL-23-induced neutrophil polarization in Th17 cytokine-related inflammatory diseases needs to be studied further. However, it has recently been reported that neutrophils can release IL-17 in areas with amyloid-β deposits and contribute to disease pathogenesis in Alzheimer's disease-like mouse models. 54 It is interesting and suggestive that the serum concentration of IL-23 has been positively correlated with IL-17-producing neutrophils in patients with fungal keratitis. 55 Neutrophils in the circulation of arthritic mice spontaneously produce IL-17 in vitro. 56 IL-17 produced by neutrophils also participates in inflammation-induced airway neutrophilia. 20 Higher levels of IL17 + CD177 + neutrophils in the peripheral blood in allergic asthma patients might contribute to disease progression. 57 tissues from mice treated as described above were detected by real-time PCR. Data are expressed as the mean ± s.d. (n = 3-5) and one representative example from three independent experiments with similar results is shown. *Po0.05, **Po0.01 and ***Po0.001 for comparisons between the indicated groups. Data were analyzed by the Mann-Whitney U-test or two-way ANOVA using SPSS software. Survival curves were analyzed by the log-rank test.
IL-17A-producing RORγt + neutrophils in the peripheral blood may amplify liver tissue injury in a hepatic ischemiareperfusion injury mouse model. 58 Thus, IL-17A-producing neutrophils contribute to a wide range of inflammatory diseases.
The biological significance and the pro-inflammatory activities of IL-23 in inflammatory and autoimmune diseases include but are not limited to the induction of IL-17 production by Th17 cells and the inhibition of immunosuppressive CD4 + CD25 + regulatory T cells. 59, 60 We observed that IL-23 can significantly induce IL-17A, IL-17F and IL-22 production in neutrophils. Our data are in line with observations showing that human neutrophils also express RORγt and upregulate the expression of IL-17A, IL-17RC and dectin-2 following IL-6 and IL-23 stimulation. 44 IL-17 production by neutrophils can be induced in various models including mucosal candidiasis, fusarium corneal infections, kidney ischemia-reperfusion injury and psoriasis. 44, [61] [62] [63] Intra-articular administration of zymosan (a TLR2 ligand) results in IL-17 production by neutrophils in an arthritis mouse model. 56 Activated peritoneal neutrophils in vitro produce IL-17A and IL-23 in response to myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies via their Fc-regions and the classical complement pathway, which contributes to the occurrence of chronic autoimmune inflammation and ultimately results in the development of local Th17-mediated autoimmunity. 64 These data collectively illustrate that neutrophils are one of the major sources of IL-17 under specific inflammatory conditions. It is known that neutrophils can produce many different cytokines such as IL-1β, TNF-α, IL-12, IL-4 and IL-10 under different stimulations. 41, 42 Therefore, based on the specific cytokine production, neutrophils may have different types of functional polarizations, similar to macrophages.
In addition to producing IL-17, IL-23-induced neutrophils also produce IL-22. The large amount of IL-17 produced by this neutrophil subset significantly contributed to the pathogenesis of DSS-induced colitis in mice. However, it has been reported that IL-22 may have opposing effects on the pathogenesis of colitis by not only enhancing inflammation and antimicrobial immunity but also increasing epithelial cell proliferation and tissue repair. 65 Thus, it is clear that the role of IL-22 produced by IL-23-induced neutrophils in colitis needs to be clarified in future studies.
IL-23 signals through IL-23R and IL-12Rβ1 to activate JAK and predominantly leads to phosphorylation and activation of STAT3 in T cells, 66 which promotes the transcription of Il23r and Rorc (encoding RORγ) and stabilizes the expression of genes encoding pro-inflammatory effector molecules including IL17A, IL17F, IL22 and CSF2. 42, 43 RORγT, RORα, IRF-7, IRF4, BATF, Sox5 and C-maf are critical transcription factors for Th17 cell induction. [45] [46] [47] Our results show that IL-23 uses the classical STAT3-RORγT/BATF pathway to induce a pro-Th17 cytokine gene expression profile in neutrophils.
In summary, our present study demonstrates a Th17 typelike polarization of neutrophils induced by IL-23. These polarized neutrophils promote colitis pathogenesis in a mouse model. These findings shed further light on the existence of neutrophil functional plasticity and polarization, which have previously been neglected. The biological significance of polarized neutrophils in other diseases needs to be investigated and may offer novel therapeutic approaches to treat neutrophil-related immune disorders.
